Cargando…
COVID-19 Vaccine Effectiveness Among Patients With Maintenance Dialysis; Observations From Population Level Cohort Studies in 2 Large Canadian Provinces
BACKGROUND: It was unknown if the effectiveness of COVID-19 vaccines could vary between regions. OBJECTIVE: To explore key differences in COVID-19 pandemics in British Columbia (BC) and Ontario (ON) and to investigate if the vaccine effectiveness (VE) among maintenance dialysis population could vary...
Autores principales: | Atiquzzaman, Mohammad, Zheng, Yuyan, Er, Lee, Djurdjev, Ognjenka, Singer, Joel, Krajden, Mel, Balamchi, Shabnam, Thomas, Doneal, Hladunewich, Michelle, Oliver, Matthew J, Levin, Adeera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285471/ https://www.ncbi.nlm.nih.gov/pubmed/37359985 http://dx.doi.org/10.1177/20543581231181032 |
Ejemplares similares
-
COVID-19 vaccine effectiveness in patients with non–dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada
por: Atiquzzaman, Mohammad, et al.
Publicado: (2022) -
Maintaining the Uptake of Peritoneal Dialysis During the COVID-19 Pandemic: A Research Letter
por: Canney, Mark, et al.
Publicado: (2021) -
Adapting Nephrology Training Curriculum in the Era of COVID-19
por: Cunningham, Amanda, et al.
Publicado: (2021) -
Determining the Longitudinal Serologic Response to COVID-19
Vaccination in the Chronic Kidney Disease Population: A Clinical Research
Protocol
por: Yau, Kevin, et al.
Publicado: (2023) -
Double-Positive Anti–Glomerular Basement Membrane Antibody and Myeloperoxidase Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Post COVID-19 mRNA vaccine: A Case Series of 4 Patients
por: Ting, Julie Anne, et al.
Publicado: (2023)